Germ Cell Cancer: Clinical Trials

10 trials for Germ Cell Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 not yet recruiting, 2 active not recruiting, 1 recruiting. 3 Phase 2, 2 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Not yet recruiting 1
Phase 12Not yet recruiting 1, Recruiting 1
Early Phase 11Not yet recruiting 1

Follow Germ Cell Cancer: new trials by email Literature Review of Germ Cell Cancer trials Research Report on Germ Cell Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose Chemotherapy In Refractory And Relapsed Germ Cell Tumors
Olaparib, Gemcitabine, Docetaxel - Germ Cell Cancer
Phase 1 / Phase 2Not yet recruitingM.D. Anderson Cancer Center362027-03-012026-10-01
A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy
Netupitant/Palonosetron Hydrochloride, Ondansetron (Control), Aprepitant - Germ Cell Cancer
Early Phase 1Not yet recruitingOttawa Hospital Research Institute102026-08-012026-06-23
YASU Research Registry: For Young Adults With Cancer
Cancer, Leukemia
TerminatedYoung Adult Survivors United1922025-02-032025-10-14
SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours
Blood test, Pathology specimen miRNA expression - Germ Cell Ovarian Cancer, Germ Cell Tumor
Not yet recruitingImperial College London242024-04-142024-03-26
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Fludarabine, Cyclophosphamide, MESNA - Pediatric Solid Tumor, Osteosarcoma
Phase 1RecruitingSt. Jude Children's Research Hospital482022-07-062026-05-19
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
Germ Cell Cancer
CompletedCopenhagen University Hospital, Rigshospitalet4302014-08-012023-11-21
Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
Brentuximab Vedotin - Germ Cell Cancer
Phase 2CompletedFondazione Michelangelo92013-05-012018-02-07
Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls
Endo-PAT2000 testing - Germ Cell Cancer
Active not recruitingMemorial Sloan Kettering Cancer Center442011-10-112025-11-10
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
Everolimus - Testicular Cancer, Germ Cell Cancer
Phase 2CompletedHannover Medical School252010-11-012015-02-25
Genomic Structural Variation in Cancer Susceptibility
Breast Cancer, Colon Cancer
Active not recruitingMemorial Sloan Kettering Cancer Center12752009-10-012025-11-04

Narrower conditions

Neoplasms, Germ Cell and Embryonal (10)  ·  Sarcoma (3)  ·  Breast Neoplasms (2)  ·  Melanoma (2)  ·  Neuroblastoma (2)  ·  Testicular Neoplasms (2)  ·  Adrenal Cortex Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Embryonal (1)  ·  Cardiovascular Diseases (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Hepatoblastoma (1)  ·  Leukemia (1)

Broader conditions

Neoplasms by Histologic Type (10)  ·  Neoplasms (9)  ·  Neoplasms by Site (6)  ·  Urogenital Diseases (5)  ·  Endocrine Gland Neoplasms (4)  ·  Endocrine System Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Gonadal Disorders (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neuroectodermal Tumors (3)

Interventions

Aprepitant (1)  ·  Brentuximab Vedotin (1)  ·  Carboplatin (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Docetaxel (1)  ·  Etoposide (1)  ·  Everolimus (1)  ·  Gemcitabine (1)  ·  Hematologic Tests (1)  ·  Mesna (1)  ·  Olanzapine (1)  ·  Ondansetron (1)  ·  Palonosetron (1)  ·  etoposide phosphate (1)

Sponsors

Memorial Sloan Kettering Cancer Center (2)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Fondazione Michelangelo (1)  ·  Hannover Medical School (1)  ·  Imperial College London (1)  ·  M.D. Anderson Cancer Center (1)  ·  Ottawa Hospital Research Institute (1)  ·  St. Jude Children's Research Hospital (1)  ·  Young Adult Survivors United (1)

Countries

United States (5)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  Italy (1)

Top investigators

Alessandro M Gianni, MD (1)  ·  Andrea Necchi, MD (1)  ·  Chris DeRenzo, MD (1)  ·  Darren Feldman, MD (1)  ·  Gedske Daugaard, MD DMSc (1)  ·  Martin H Fenner, MD (1)  ·  Roberto Salvioni, MD (1)  ·  Srdjan Saso, PhD MRCOG MRCS (1)  ·  Yago Nieto, MD, PHD (1)  ·  Zsofia Stadler, MD (1)

Results publications

PMID 30232558

NIH funding

2009 (1)